Comparisons of Treatment for HER2-Positive Breast Cancer between Chinese and International Practice: A Nationwide Multicenter Epidemiological Study from China

OBJECTIVE: To better understand the status of medical treatment for human epidermal growth factor receptor 2 (HER2)-positive breast cancer and the differences between the Chinese and the international clinical practice. METHODS: This was a retrospective, nationwide, multicenter, epidemiological stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Yi-Qun, Yi, Zong-Bi, Yu, Pei, Wang, Wen-Na, Ouyang, Qu-Chang, Yan, Min, Wang, Xiao-Jia, Hu, Xi-Chun, Jiang, Ze-Fei, Huang, Tao, Tong, Zhong-Sheng, Wang, Shu-Sen, Yin, Yong-Mei, Li, Hui, Yang, Run-Xiang, Yang, Hua-Wei, Teng, Yue-E., Sun, Tao, Cai, Li, Li, Hong-Yuan, Ouyang, Xue-Nong, He, Jian-Jun, Liu, Xin-Lan, Yang, Shun-E., Qiao, You-Lin, Fan, Jin-Hu, Wang, Jia-Yu, Xu, Bing-He
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457988/
https://www.ncbi.nlm.nih.gov/pubmed/34567118
http://dx.doi.org/10.1155/2021/6621722

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457988/
https://www.ncbi.nlm.nih.gov/pubmed/34567118
http://dx.doi.org/10.1155/2021/6621722

Ejemplares similares